New clues reveal how cells respond to stress
Inflammasome protein complexes form in response to signals associated with danger, such as an infection or environmental stress, and trigger the innate immune response. The serine protease dipeptidyl peptidase 9, or DPP9, forms a dimer in its active conformation and interacts with components of inflammasomes to prevent unnecessary activation. Scientists know that synthetic inhibitors of DPP9 activate certain inflammasomes. However, whether a cell-intrinsic molecule can inhibit this enzyme remains an open question. Therefore, Lydia Tsamouri, Jeffrey Hsiao and colleagues from the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan Kettering Cancer Center investigated DPP9 interaction partners. They examined a connection between DPP9 and redox sensor KEAP1 in their recent Journal of Biological Chemistry article.
Using a fluorogenic probe that functions as a DPP9 substrate, the authors established that KEAP1 inhibits DPP9 activity in cells. They also found that KEAP1 can only inhibit DPP9 when both are introduced into cells at the same time via transfection with complementary DNA, or cDNA, that encodes each protein, before DPP9 dimerizes; newly introduced KEAP1 could not inhibit DPP9 already present in cells. The researchers hypothesized that KEAP1 interacts with DPP9 in a state different from its folded dimeric structure and that a cellular event or biomolecule could force DPP9 to adopt this alternative conformation. They tested multiple compounds, including electron transport chain inhibitors and oxidants like hydrogen peroxide, but they have not yet found a condition that leads to KEAP1–DPP9 complex formation and DPP9 inactivation.
Future experiments will focus on identifying a signal or molecules that could change DPP9’s conformation and whether the DPP9–KEAP1 interaction directly initiates inflammasome activation. Outlining the full DPP9 pathway involving inflammasomes will help scientists understand how cells convert danger signals into immune action and restrain unnecessary activation.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

When things get SAPpy: Novel insights into complement
Researchers have defined interactions between an innate immune protein and two of its known binding partners. They identified potential areas of crosstalk between the two binding interactions.

Glutathione pathway implicated in rare disease
Researchers found that glutathione metabolism plays a central role in the pathogenesis of rare disease methylmalonic aciduria using a novel multiomics approach.

A p-value for proteins
Kyoto University researchers developed UniScore, a new tool that uses a target-decoy method to filter false positives in proteomic searches, helping scientists set thresholds and improve reliability when analyzing complex protein data.

Novel way to uncover tumor microenvironment proteomics
Researchers at the Weizmann Institute of Science developed a novel single-cell approach that facilitates the study of proteins surrounding lung cancer cells.

Sizing up cells: How stem cells know when to divide
Stanford University researchers find that stem cells control their size early in cell division across living multicellular systems.

When oncogenes collide in brain development
Researchers at University Medical Center Hamburg, found that elevated oncoprotein levels within the Wnt pathway can disrupt the brain cell extracellular matrix, suggesting a new role for LIN28A in brain development.